Back to Announcements

Ranomics Partners with Castle Medical to classify VUS in Clinical Tests

Castle Medical, a genetic testing company located in Atlanta, Georgia, has partnered with Ranomics to use its functional studies data to classify Variants of Unknown Significance in genetic tests for the BRCA1 gene. Following the American College of Medical Genetics (ACMG) guidelines for the interpretation of sequence variants, and in combination with its multiple gene sequencing platforms, Castle Medical plans to leverage Ranomics’ database to classify variants in genes that predispose patients to hereditary breast cancer.

About Castle Medical

Castle Medical is a leading national healthcare solutions provider in the United States. Using state-of-the-art technologies, Castle Medical supports physicians, patients, and employers through the enhancement of pain management practices and promotion of better health through cutting edge clinical laboratory and genetics testing. Castle Medical is committed to revolutionizing healthcare management with the delivery of products and services of the highest quality, precision, accuracy and reliability.

Ranomics
info@ranomics.com
600 University Ave
Toronto, Ontario, Canada
M5G 1X5

internal secret white paper